Company is one of six awarded a place on the £4bn ProCure22 framework due to start on 1 October
Interserve, the international support services and construction group, has secured one of six places on the Department of Health’s £4bn ProCure22 (P22) construction framework, which is due to start on 1 October, 2016.
The award continues Interserve’s 14-year role on UK health frameworks, through which it has delivered more than £1bn worth of diverse healthcare facilities across more than 250 projects, including the UK’s first Proton Beam therapy unit, currently under construction at The Christie in Manchester.
Interserve is one of six companies that have been awarded a place on the framework.
‘P22 is strategically very important to our long-term business objectives in the healthcare sector. Ever since the first pilot framework was launched in 2002, we have sought to deliver high quality clinical space for the NHS,’ said Adrian Ringrose, Interserve’s Chief Executive.
‘We have been working towards securing a place on the P22 Framework since 2014. Together with our existing clients and experienced supply chain, we have sought to balance the complex needs of the sector with the provision of consistent and capable supply side teams that can help the NHS drive efficiency in its capital resource allocation.’